A new option for the "no-option" patient with refractory angina?

Catheterization and Cardiovascular Interventions

Volumn 74, Issue 3, 2009, Pages 395-397

  Henry, Timothy D ^a  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; RANOLAZINE;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANGIOGENESIS; CARDIOVERSION; CLINICAL TRIAL; CRYOTHERAPY; EXERCISE TOLERANCE; HEART ARRHYTHMIA; HEART MUSCLE INJURY; HEART MUSCLE REVASCULARIZATION; HEART TAMPONADE; HEART VENTRICLE TACHYCARDIA; HUMAN; MEDICAL DECISION MAKING; MORTALITY; NOTE; OUTCOME ASSESSMENT; PERICARDIAL EFFUSION; QUALITY OF LIFE; STEM CELL TRANSPLANTATION; TREATMENT CONTRAINDICATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CRYOSURGERY; EQUIPMENT DESIGN; HEART CATHETERIZATION; HOSPITALIZATION; INSTRUMENTATION; METHODOLOGY; PATHOPHYSIOLOGY; PATIENT SELECTION; SCINTISCANNING; TREATMENT FAILURE;

ANGINA PECTORIS; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CRYOSURGERY; EQUIPMENT DESIGN; EXERCISE TOLERANCE; HEART CATHETERIZATION; HUMANS; MYOCARDIAL REVASCULARIZATION; NEOVASCULARIZATION, PHYSIOLOGIC; PATIENT SELECTION; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE;

EID: 70350517301     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22223     Document Type: Note

References (11)

1. Gallo R, et al. A first-in-man study of percutaneous myocardial cryotreatment in nonrevascularizable patients with refractory angina. Catheter Cardiovasc Interv, In press.
2. Jolicoeur EM, Granger CB, Henry TD, Holmes DJ, Pepine C, Mark D, Chaitman BR, Gersh BJ, Ohman EM, on behalf of the Working Group Members. Clinical and research issues regarding chronic advanced coronary artery disease: Report from a think tank. I. Contemporary and emerging therapies. Am Heart J 2008;155:418-434.
3. Mannheimer C, Camici P, Chester MR, Collins A, DeJongste M, Eliasson T, Follath F, Hellemans I, Herlitz J, Lüscher T, Pasic M, Thelle D. The problem of chronic refractory angina: Report from the European society of cardiology joint study group on the treatment of refractory angina. Eur Heart J 2002;23:355-370. (Pubitemid 35204196)
4. Mukherjee D, Comella K, Bhatt DL, Roe MT, Patel V, Ellis SG. Clinical outcome of a cohort of patients eligible for therapeutic angiogenesis or transmyocardial revascularization. Am Heart J 2001;142:72-74. (Pubitemid 32595376)
5. Bernstein SJ, Brorsson B, Aberg T, Emanuelsson H, Brook RH, Werko L. Appropriateness of referral of coronary angiography patients in Sweden. SECOR/SBU project group. Heart 1999;81:470-477. (Pubitemid 29234305)
6. Satran D, Traverse JH, Barsness GW, Lerman A, Simari RD, Poulose AK, Johnson RK, Henry TD. Emerging therapies for refractory angina. Minn Med 2008;91:36-39.
7. Manchanda A, Soran O. Enhanced external counterpulsation and future directions: Step beyond medical management for patients with angina and heart failure. J Am Coll Cardiol 2007;50:1523-1531. (Pubitemid 47532332)
8. Leon MB, Kornowski R, Downey WE, Weisz G, Baim DS, Bonow RO, Hendel RC, Cohen DJ, Gervino E, Laham R, Lembo NJ, Moses JW, Kuntz RE. A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. J Am Coll Cardiol 2005;46:1812-1819. (Pubitemid 41579801)
9. Stone PH, Gratsiansky NA, Blokhin A, Huang IZ, Meng L; ERICA Investigators. Antianginal efficacy of ranolazine when added to treatment with amlodipine: The ERICA (efficacy of ranolazine in chronic angina) trial. J Am Coll Cardiol 2006;48:566-575. (Pubitemid 44093970)
10. Henry TD, Grines CL, Watkins MW, Dib N, Ptratt C, Barbeau G, Moreadith R, Andrasfay T, Enger RL. Effects of Ad5FGF-4 in patients with angina: An analysis of pooled data from the AGENT-3 and AGENT-4 trials. J Am Coll Cardiol 2007;50:1038-1046. (Pubitemid 47354223)
11. Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M, Poh KK, Weinstein R, Kearney M, Chaudhry M, Burg A, Eaton L, Heyd L, Thorne T, Shturman L, Hoffmeister P, Story K, Zak V, Dowling D, Traverse JH, Olson RE, Flanagan J, Sodano D, Murayama T, Kawamoto A, Kusano KF, Wollins J, Welt F, Shah P, Soukas P, Asahara T, Henry TD. Intramyocardial transplantation of autologous CD341 stem cells for intractable angina: A phase I/IIa double-blind, randomized controlled trial. Circulation 2007;115:3165-3172. (Pubitemid 47018140)